Alignment Healthcare, Inc. filed a Form 8-K with the SEC on October 8, 2026, detailing changes in its Medicare Advantage Star Ratings. This is important for readers as these ratings can affect the company's revenue and its ability to attract new members.

Background on Alignment Healthcare

Alignment Healthcare is a health insurance company based in Orange, California. It focuses on providing Medicare Advantage plans, which are private health insurance plans that provide Medicare benefits. The company is incorporated in Delaware and is publicly traded on the NASDAQ under the ticker symbol ALHC.

Details of the Filing

The SEC filing, identified by Accession Number 0001628280-26-065470, is a Form 8-K, which is used to report unscheduled material events or corporate changes. In this case, the filing includes a Regulation FD Disclosure regarding the company's Star Ratings for its Medicare Advantage plans.

According to the filing, the Centers for Medicare & Medicaid Services (CMS) announced its 2027 Star Ratings on the same day. Alignment Healthcare expects its California HMO health plan contract (H3815) to receive a 3.5-Star Rating for the 2027 rating year, down from a 4.0-Star Rating in 2026. This particular plan serves about 75% of the company’s health plan members. However, the company anticipates maintaining a 4.0-Star Rating or higher for its other six eligible plans, with three of those plans achieving a 4.5-Star Rating.

The filing states, "The decline in Stars performance was driven primarily by higher industry cut points and a decline in certain triple-weighted measures across Health Outcomes Survey (HOS) and Part D." Additionally, CMS's decision to eliminate bonus calculations related to the Excellent Health Outcomes for All Index also contributed to the decline.

To address these challenges, Alignment Healthcare plans to implement various initiatives aimed at enhancing member and provider engagement and improving quality oversight. The company also intends to pursue administrative appeals and possibly litigation regarding certain CMS calculations that it believes are inconsistent with applicable law.

Impact of the Filing

The changes in Star Ratings could significantly affect Alignment Healthcare's business operations. A lower rating may impact the company's quality bonus payments for fiscal year 2028, although the company expects its risk-sharing arrangements with providers to help mitigate some of these impacts. The filing indicates that the ratings will not affect the company’s revenue for fiscal years 2026 or 2027.

Members of Alignment Healthcare's plans, potential new members, and investors may all feel the effects of these changes. Lower Star Ratings can influence member satisfaction and retention, as well as the company's reputation in the competitive Medicare Advantage market.

What's Next?

The filing does not specify what happens next regarding the rating appeals or litigation. However, Alignment Healthcare has indicated that it will continue to pursue options to mitigate the potential financial impacts of the rating changes and enhance its service offerings.